Cigna Corporation

Glass Lewis Recommends Cigna Shareholders Vote “FOR” Acquisition Of Express Scripts

A Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Cigna Shareholders Vote “FOR” Acquisition Of Express Scripts

Glass Lewis Joins ISS in Recommending Cigna Shareholders Vote for the Express Scripts Acquisition

Cigna Reminds Shareholders to Vote “FOR” the Transformative Combination Today


Q2 hedge fund letters, conference, scoops etc

Cigna Corporation

BLOOMFIELD, Conn.–(BUSINESS WIRE)–Cigna Corporation (NYSE:CI) (“Cigna” or the “Company”) announced that independent proxy advisory firm Glass Lewis & Co. (“Glass Lewis”) has joined Institutional Shareholder Services (“ISS”) in recommending that Cigna shareholders vote to approve the proposed acquisition of Express Scripts (NASDAQ:ESRX) at the Company’s upcoming special meeting scheduled for August 24, 2018.

“We welcome the favorable recommendations from both Glass Lewis and ISS as momentum continues to build in support of our merger with Express Scripts,” said David M. Cordani, Cigna President and Chief Executive Officer. “Their recommendations underscore the significant shareholder value that this transformative merger will deliver in a highly dynamic market environment.”

As support for its favorable recommendation, Glass Lewis noted the following:

  • “…[W]e find the proposed merger both strategically and financially compelling, structured in a reasonable manner from a valuation standpoint for Cigna shareholders.”
  • “The merger represents an attractive opportunity to create a more diverse and integrated business model in the evolving health care services industry which will be better positioned to serve consumers, adapt to competitive and structural challenges, respond to regulatory changes, capitalize on growth opportunities and potentially realize significant incremental cost savings and operational efficiencies.”
  • “Factoring in the significant synergy potential and earnings accretion forecasted by Cigna, we believe the merger represents an attractive value proposition for Cigna and its shareholders.”
  • “We also have confidence in the combined management team to navigate the evolving health care industry while drawing upon their transaction integration experience with the objective of delivering accretive returns for shareholders.”
  • “Based on these factors, along with the support of the board, we believe the proposed stock issuance for the merger is in the best interests of shareholders.”

The Cigna Board of Directors encourages Cigna shareholders to vote “FOR” the proposal to adopt the merger agreement at the special meeting.

Cigna’s special meeting of shareholders is scheduled to take place on Friday, August 24, 2018, at 9:30 a.m., Eastern Time. Cigna shareholders of record at the close of business on July 10, 2018 will be entitled to vote at the special meeting.

If shareholders have questions about the transaction, or need assistance in voting shares, please contact Cigna’s proxy solicitor, Innisfree M&A Incorporated: toll-free at (877) 750-9498. Additional materials addressing the Express Scripts transaction, including more information on the strong strategic rationale and expected financial results, are available on Cigna and Express Scripts’ joint transaction website:

About Cigna

Cigna Corporation (NYSE:CI) is a global health service company dedicated to helping people improve their health, well-being and sense of security. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Life Insurance Company of North America, Cigna Life Insurance Company of New York, or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance. Cigna maintains sales capability in over 30 countries and jurisdictions, and has more than 95 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit For more information about Cigna’s proposed acquisition of Express Scripts, please visit


Saved Articles

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.


Congrats! Are you a smart person?

We have an exclusive targeted & limited time offer for being a sophisticated and loyal reader.

ValueWalkPremium is a website and newsletter on the latest industry news much of which is not in the public domain and obtained via our sources.

We also have 10 years of resources on how to use this information to better your investment process.

Sign up for  today and get our exclusive content for 40% off. This is our second biggest discount ever!!

Use coupon code VIP20 or click on the button below

Limited time offer only ENDS 2/29/2019 or after next 25 subscribers take advantage whichever comes first – please do not share this discount with others